Your browser doesn't support javascript.
loading
Myeloablative I-131-tositumomab with escalating doses of fludarabine and autologous hematopoietic transplantation for adults age ≥ 60 years with B cell lymphoma.
Gopal, Ajay K; Gooley, Ted A; Rajendran, Joseph G; Pagel, John M; Fisher, Darrell R; Maloney, David G; Appelbaum, Frederick R; Cassaday, Ryan D; Shields, Andrew; Press, Oliver W.
Afiliação
  • Gopal AK; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. Electronic address: agopal@u.washington.edu.
  • Gooley TA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Rajendran JG; Division of Nuclear Medicine, Department of Radiology, University of Washington, Seattle, Washington.
  • Pagel JM; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Fisher DR; Pacific Northwest National Laboratory, Richland, Washington.
  • Maloney DG; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Appelbaum FR; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Cassaday RD; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Shields A; Division of Nuclear Medicine, Department of Radiology, University of Washington, Seattle, Washington.
  • Press OW; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Biol Blood Marrow Transplant ; 20(6): 770-5, 2014 Jun.
Article em En | MEDLINE | ID: mdl-24530971
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vidarabina / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B / Transplante de Células-Tronco Hematopoéticas / Radioisótopos do Iodo / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vidarabina / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B / Transplante de Células-Tronco Hematopoéticas / Radioisótopos do Iodo / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article